Study protocol to assess the effectiveness of pharmacistmanaged stop-smoking services : A randomized controlled trial
More details
Hide details
Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Tamil Nadu, India
KG Hospital and Postgraduate Medical Institute, Tamil Nadu, India
Department of Pharmaceutical Analysis, RVS College of Pharmaceutical Sciences, Tamil Nadu, India
Sam J. U. Chander   

Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore 641044, Tamil Nadu, India
Publication date: 2020-02-27
Submission date: 2020-01-04
Final revision date: 2020-02-17
Acceptance date: 2020-02-17
Popul. Med. 2020;2(February):4
According to the Global Adult Tobacco Survey (GATS), there were 267 million tobacco users in India during 2016–2017. It is also estimated that about one million people die each year due to tobacco-related diseases in India. Tobacco cessation is the only way by which tobacco-related morbidity and mortality can be avoided. Healthcare workers are ideal professionals to encourage smoking cessation, and pharmacists are the most accessible healthcare providers who can initiate a change in the smoking behavior of patients. Many studies, worldwide, have demonstrated the effectiveness of pharmacists in delivering a smoking cessation program, but studies demonstrating the effectiveness of pharmacist-managed smoking cessation services in India are almost non-existent. This protocol aims to test the effectiveness of Pharmacist-Managed Stop Smoking Services (PM-S3), a structured smoking cessation program delivered by a clinical pharmacist. A prospective, randomized, controlled trial is being conducted at a 550-bed tertiary care hospital in Coimbatore, India. Participants are randomly assigned to either an interventional group, where they receive at least four sessions of face-to-face, patient-specific, structured smoking cessation counselling by a clinical pharmacist for approximately 30 minutes each, or to usual-care group where they receive brief smoking cessation counseling by a physician and/or nurse. Both groups are provided with nicotine replacement therapy, if warranted. The primary outcome of smoking cessation is measured in two ways, viz self-reported abstinence and an exhaled carbon monoxide (CO) test. If proven effective, this model can be used as a framework for establishing pharmacist-managed stop smoking clinics in all hospitals throughout India to decrease the overall smoking burden.
We are grateful to the study community and hospital authorities and workers for their support during study implementation.
The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
There was no source of funding for this research.
SJUC participated in conception of the study, study design, and drafted this protocol. SS and SSWD participated in study design. SJUC and SS will assess the effect of the intervention. All authors read and approved the final manuscript.
Not commissioned; externally peer reviewed.
World Health Organization. WHO report on the global tobacco epidemic, 2013 -Enforcing bans on tobacco advertising, promotion and sponsorship. Geneva, Switzerland: World Health Organization; 2013. Accessed January 4, 2020.
Oberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: A retrospective analysis of data from 192 countries. Lancet. 2011;377(9760):139-146. doi:10.1016/s0140-6736(10)61388-8
World Health Organization. GATS 2: Global Adult Tobacco Survey Fact Sheet, India 2016-17. Accessed Jnauary 4, 2020.
Brose LS, West R, Mcdermott MS, et al. What makes for an effective stop-smoking service? Thorax. 2011;66(10):924-926. doi:10.1136/thoraxjnl-2011-200251
Sundeep Salvi, Aurag Agarwal. India Needs a National COPD Prevention and Control Programme. J Assoc Physicians India. 2012;60(Suppl):5-7. PMID:23155805.
Jindal SK, Gupta D, Aggarwal AN. Guidelines for management of chronic obstructive pulmonary disease in India: a guide for physicians. Indian J Chest Dis Allied Sci. 2004;46(2):137-193. PMID:15072332.
Jindal SK, Aggarwal AN, Gupta D. A review of population studies from India to estimate national burden of chronic obstructive pulmonary disease and its association with smoking. Indian J Chest Dis Allied Sci. 2001;43(3):139-147. PMID:11529432.
World Health Organization. Report on Tobacco Control in India. New Delhi, India: Ministry of Health and Family Welfare, Government of India; 2004. Accessed January 4, 2020.
Centers for Disease Control and Prevention: Smoking and Tobacco Use Cessation and Interventions. Accessed Januaru 4, 2020.
Roth MT, Andrus MR, Westman EC. Outcomes from an outpatient smoking cessation clinic. Pharmacotherapy. 2005;25(2):279-288. doi:10.1592/phco.
Raj Kumar, Rajendra Prasad. Smoking Cessation: An Update. Indian J Chest Dis Allied Sci. 2014;56(3):161-169. PMID:25823111.
Rao M, Rao KD, Kumar AK, Chatterjee M, Sundararaman T. Human resources for health in India. Lancet. 2011;377(9765):587-598. doi:10.1016/s0140-6736(10)61888-0
Thankappan KR, Mini GK, Hariharan M, Sarma PS, Vijayakumar G, Nichter M. Smoking cessation among diabetes patients: one year follow-up results of a randomized controlled trial in Kerala, India. Diabetes. 2013;13(1):A1-A98. doi:10.1186/1471-2458-13-47
Vitale F. Professional intervention for smoking cessation. The contribution of the pharmacist. Eur J Public Health. 2000;10(3):21-24. doi:10.1093/eurpub/10.suppl_3.21
Dhingra S, Kumria R. A case report on the significance of clinical pharmacy services in India. Clin Case Rep. 2014;2(3):86-87. doi:10.1002/ccr3.63
Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43(2):194-201. doi:10.1345/aph.1l556
Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Ann Intern Med. 2013;158(3):200. doi:10.7326/0003-4819-158-3-201302050-00583
Hudmon KS, Berger BA. Pharmacy applications of the transtheoretical model in smoking cessation. Am J Health Syst Pharm. 1995;52(3):282-287. doi:10.1093/ajhp/52.3.282
Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2000.
DRUGDEX® Evaluations: Nicotine. http://www.micromedexsolutions.... Accessed January 4, 2020.
DRUGDEX® Evaluations: Nicotine polacrilex. http://www.micromedexsolutions.... Accessed January 4, 2020.
Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001;96(2):325-331. doi:10.1046/j.1360-0443.2001.96232516.x
Vial RJ, Jones TE, Ruffin RE, Gilbert AL. Smoking cessation program using nicotine patches: linking hospital to the community. J Pharm Pract Res. 2002;32(1):57-62. doi:10.1002/jppr200232157
Carroll P, Rois R, Sarson D, Flynn J. A community pharmacy based smoking cessation program using transdermal nicotine replacement therapy: actions and outcomes. Aust Pharmacist. 2000;19:51-55.
Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomized controlled trial in Scotland. Tob Control. 1998;7(3):253-261. doi:10.1136/tc.7.3.253
Zillich AJ, Ryan M, Adams A, Yeager B, Farris K. Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life. Pharmacotherapy. 2002;22(6):759-765. doi:10.1592/phco.22.9.759.34073
Smith MD, McGhan WF, Lauger G. Pharmacist counseling and outcomes of smoking cessation. Am Pharm. 1995;NS35(8):20-29. doi:10.1016/s0160-3450(15)30095-7
Kennedy DT, Giles JT, Chang ZG, Small RE, Edwards JH. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42(1):51-56. doi:10.1331/108658002763538071
Dent LA, Scott JG, Lewis E. Pharmacist-managed tobacco cessation program in Veterans Health Administration community-based outpatient clinic. J Am Pharm Assoc. 2004;44(6):700-715. doi:10.1331/1544345042467290